BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

Original from: PR Newswire

BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced a collaboration with Epic, the nation's most widely used comprehensive electronic health record (EHR). The agreement, signed in December 2025, will integrate BillionToOne's prenatal and oncology testing portfolio with Epic's Aura diagnostics suite.

Through the integration, clinicians will be able to order BillionToOne's UNITY Complete prenatal test as well as Northstar Select and Northstar Response liquid biopsy tests directly within Epic. Discrete test results then flow back into the electronic health record, where they can power downstream clinical decision support and a simpler experience for patients and providers in health systems, community practices, maternal-fetal medicine practices, and oncology clinics.

"Collaborating with Epic advances our goal of making high-quality molecular diagnostics easier to access and simpler to use in everyday clinical care," said Oguzhan Atay, co-founder and CEO of BillionToOne. "By integrating our tests directly into the EHR, we're helping clinicians spend less time navigating logistics and more time focusing on patient care, whether supporting expectant families or guiding cancer treatment decisions."

UNITY Complete is the first and only clinically validated non-invasive prenatal test to provide direct fetal risk assessment for up to 14 recessive and X-linked conditions, aneuploidies, and more from a single maternal blood sample. For oncology care, Northstar Select helps identify appropriate therapies for patients with advanced cancer, while Northstar Response enables treatment monitoring over time.

With results delivered directly into Epic and available through the MyChart patient portal, the integration supports faster clinical decision making and a more connected patient experience.

"BillionToOne's use of Aura integrates oncology and prenatal tests and results where they matter—inside the clinician's workflow, at the moment of decision," said Seth Hain, senior vice president of research and development at Epic.

Source: BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare